US EditionFrench Artificial Heart Maker Carmat Files for Insolvency
22 Articles
22 Articles
"It Was a Complicated Project that Took Too Much Time and Money": Why Carmat's Heart Stopped Beating
RECIT - In the absence of funding, the inventor of the artificial heart has requested the opening of a judicial reorganization procedure.
After decades of research and hope, the French company announced its cessation of payments on Monday. But promises that patient follow-up will be assured.
The French manufacturer of artificial heart Carmat announces its cessation of payment and asks for the opening of a legal remedy procedure. In financial difficulty, the company aims to continue its activities while ensuring the follow-up of patients equipped with the Aeson device.
Carmat had launched a donation campaign to ensure the continuation of its activities. But without raising the necessary funds, the company announced this Monday that it was at the end of the payments, demanding the opening of a judicial reorganization procedure. - Artificial heart maker Carmat declares itself to be at the end of payments (Economy).
The French manufacturer of a temporary artificial heart intended for patients suffering from severe heart failure, Carmat, announced on Monday that he was terminating payments and requesting the opening of a judicial remedy procedure. ...
The French manufacturer of a temporary artificial heart intended for patients with severe heart failure requested on Monday the opening of a judicial remedy procedure and the suspension of its stock exchange price.
Coverage Details
Bias Distribution
- 38% of the sources are Center, 38% of the sources lean Right
To view factuality data please Upgrade to Premium
